Related Experiment Video
Updated: Jul 22, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
YWK-II/APLP2 inhibits TGF-β signaling by interfering with the TGFBR2-Hsp90 interaction
Amannisa Tuersuntuoheti1, Qinshan Li2, Yu Teng1
1Department of Biochemistry and Molecular Biology, State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China.
Abstract:
Transforming growth factor-β (TGF-β) regulates multiple cellular biological processes by activating TGF-β type I receptors (TGFBR1) and type II receptors (TGFBR2), and Hsp90 stabilizes these receptors through specific interactions. In many malignancies, one of the most deregulated signaling pathways is the TGF-β signaling pathway, which is often inactivated by mutations or deregulation of TGF-β type II receptors (TGFBR2). However, the molecular mechanisms are not well understood. In this study, we show that YWK-II/APLP2, an immediately early response gene for TGF-β signaling, inhibits TGF-β signaling by promoting the degradation of the TGFBR2 protein. Knockdown of YWK-II/APLP2 increases the TGFBR2 protein level and sensitizes cells to TGF-β stimulation, while YWK-II/APLP2 overexpression destabilizes TGFBR2 and desensitizes cells to TGF-β. Mechanistically, YWK-II/APLP2 is associated with TGFBR2 in a TGF-β activity-dependent manner, binds to Hsp90 to interfere with the interaction between TGFBR2 and Hsp90, and leads to enhanced ubiquitination and degradation of TGFBR2. Taken together, YWK-II/APLP2 is involved in negatively regulating the duration and intensity of TGF-β/Smad signaling and suggests that aberrantly high expression of YWK-II/APLP2 in malignancies may antagonize the growth inhibition mediated by TGF-β signaling and play a role in carcinogenesis.
Insights
YWK-II/APLP2 inhibits transforming growth factor-β (TGF-β) signaling by promoting the degradation of TGF-β type II receptors (TGFBR2). High YWK-II/APLP2 levels may antagonize TGF-β
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Biology
Background:
- Transforming growth factor-β (TGF-β) signaling is crucial for cellular processes and often deregulated in malignancies.
- TGF-β signaling involves TGF-β type I and type II receptors (TGFBR1 and TGFBR2), stabilized by Hsp90.
- Inactivation of TGF-β signaling in cancer is frequently linked to TGFBR2 deregulation, but mechanisms remain unclear.
Purpose of the Study:
- To investigate the role of YWK-II/APLP2 in regulating TGF-β signaling.
- To elucidate the molecular mechanisms by which YWK-II/APLP2 affects TGFBR2 stability and function.
Main Methods:
- Investigated YWK-II/APLP2's effect on TGFBR2 protein levels and TGF-β signaling.
- Utilized knockdown and overexpression of YWK-II/APLP2.
- Examined YWK-II/APLP2's interaction with TGFBR2 and Hsp90.
- Assessed TGFBR2 ubiquitination and degradation.
Main Results:
- YWK-II/APLP2 inhibits TGF-β signaling by promoting TGFBR2 degradation.
- Knockdown of YWK-II/APLP2 increases TGFBR2 levels and sensitizes cells to TGF-β.
- Overexpression of YWK-II/APLP2 destabilizes TGFBR2 and desensitizes cells.
- YWK-II/APLP2 interferes with the TGFBR2-Hsp90 interaction, leading to enhanced ubiquitination and degradation.
Conclusions:
- YWK-II/APLP2 negatively regulates the duration and intensity of TGF-β/Smad signaling.
- Aberrant YWK-II/APLP2 expression in malignancies may counteract TGF-β-mediated growth inhibition.
- YWK-II/APLP2 plays a role in carcinogenesis by disrupting TGF-β signaling.
Related Concept Videos
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
The Intrinsic Apoptotic Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Hedgehog Signaling Pathway

